Mixed lineage kinase 3 negatively regulates IKK activity and enhances etoposide-induced cell death  by Cole, Eric T. et al.
Biochimica et Biophysica Acta 1793 (2009) 1811–1818
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrMixed lineage kinase 3 negatively regulates IKK activity and enhances etoposide-
induced cell death
Eric T. Cole 1, Yu Zhan 1, Widian F. Abi Saab, Amanda C. Korchnak, Brian P. Ashburner, Deborah N. Chadee ⁎
Department of Biological Sciences, University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606, USA⁎ Corresponding author. Tel.: +1 419 530 5077; fax:
E-mail address: deborah.chadee@utoledo.edu (D.N.
1 Both authors contributed equally to the work.
0167-4889/$ – see front matter © 2009 Elsevier B.V. A
doi:10.1016/j.bbamcr.2009.09.014a b s t r a c ta r t i c l e i n f oArticle history:
Received 2 April 2009
Received in revised form 21 August 2009
Accepted 18 September 2009
Available online 25 September 2009
Keywords:
MLK3
NF-κB
Apoptosis
IKKMixed lineage kinase 3 (MLK3) is a mitogen activated protein kinase kinase kinase (MAP3K) that activates
multiple MAPK signaling pathways. Nuclear factor kappa B (NF-κB) is a transcription factor that has
important functions in inﬂammation, immunity and cell survival. We found that silencing mlk3 expression
with RNA interference (RNAi) in SKOV3 human ovarian cancer epithelial cells and NIH-3T3 murine
ﬁbroblasts led to a reduction in the level of the inhibitor of kappa B alpha (IκBα) protein. In addition, we
observed enhanced basal IκB kinase (IKK) activity in HEK293 cells transiently transfected with MLK3 siRNA
and in NIH3T3 cells stably expressing MLK3 shRNA (shMLK3). Furthermore, the basal level of NF-κB-
dependent gene transcription was elevated in shMLK3 cells. Silencing mlk3 expression conferred resistance
of cells to etoposide-induced apoptotic cell death and overexpression of wild type MLK3 (MLK3-WT) or
kinase-dead MLK3 (MLK3-KD) promoted apoptotic cell death and cleavage of poly (ADP-ribose) polymerase
(PARP). Overexpression of MLK3-WT or MLK3-KD enhanced etoposide-induced apoptotic cell death and
cleavage of PARP. These data suggest that MLK3 functions to limit IKK activity, and depleting MLK3 helps
protect cells from etoposide-induced cell death through activation of IKK-dependent signaling.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Mitogen activated protein kinases (MAPKs) respond to diverse
stimuli to regulate expression of speciﬁc genes and modulate cellular
processes such as proliferation, motility, differentiation, survival and
apoptosis [1]. MAPKs are organized in a three-tiered signaling module
whereby a MAP3K phosphorylates and activates a MAPK kinase
(MAP2K) that, in turn, phosphorylates and activates a MAPK [1]. In
response to various stimuli, activated MAPKs phosphorylate both
cytoplasmic and nuclear substrates including transcription factors
that ultimately result in the transcription of speciﬁc genes [1].
The MLKs are a family of MAP3Ks that activate the c-Jun N-
terminal kinase (JNK) and p38 MAPK signaling pathways [2]. Upon
activation, MLKs directly phosphorylate and activate MAP2Ks MKK4/
SEK1, and MKK3/6 [3,4]. Activated MKK4/SEK1 and MKK3/6 directly
phosphorylate and activate JNK and p38, respectively [1]. MLK3 is
activated by tumor necrosis factor alpha (TNF-α), epidermal growth
factor (EGF), T cell receptor co-stimulation, transforming growth
factor beta (TGF-β), sorbitol, ceramide and nerve growth factor (NGF)
deprivation in neuronal cells [2,5–9].
RNAi studies showed that MLK3 can promote microtubule
instability, is required for cell proliferation in epithelial and ﬁbroblast+1 419 30 7737.
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ll rights reserved.cells, and is required for TNF and EGF activation of extracellular signal-
regulated kinase (ERK) and JNK [10,11]. Results from studies with
mice that have a targeted disruption ofmlk3 conﬁrmed a requirement
for MLK3 in TNF activation of JNK [12]. MLK3 stimulates neuronal
apoptosis through activation of JNK and neuronal apoptosis induced
by nerve growth factor (NGF)withdrawal can be blocked by dominant
negative MLK3 or pharmacological inhibitors of the MLKs [13–15].
Interestingly, AKT inhibits MLK3 kinase activity and blocks MLK3-
dependent activation of JNK and apoptosis in HEK293 cells [16].
NF-κB is a transcription factor that has important functions in
inﬂammation, immunity, apoptosis, cell cycle regulation and cell
adhesion [17,18]. In the canonical pathway of NF-κB activation, NF-κB
is retained in the cytoplasm by association with its inhibitor, IκBα
[19]. Upon exposure of cells to activating stimuli such as TNF,
interleukin 1 (IL-1) and ultraviolet radiation, an IKK kinase (IKKK) is
activated that phosphorylates and activates IKK. Activated IKK then
phosphorylates IκBα on Ser32 and Ser36 [19]. Phosphorylation of
IκBα on these sites promotes ubiquitination and proteosomal
degradation of IκBα, resulting in release of NF-κB from IκBα and
exposure of the NF-κB nuclear translocation sequence. NF-κB then
translocates to the nucleus and activates gene transcription [19].
Similar to other MAP3Ks like MEKK1 and NF-κB inducing kinase
(NIK), MLK3 can phosphorylate IKKα and/or IKKβ in vitro [20–22].
Hehner et al. [6] observed that overexpression of MLK3 in T cells led to
the activation of IKK. In that study, MLK3 was found to interact with
IKKα and IKKβ and MLK3 phosphorylated IKK-α/β in vitro on Ser32
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overexpression of MLK3 did not lead to activation of IKK in HeLa cells.
Thus, the role of MLK3 in IKK activation remains elusive.
To investigate the function of MLK3 in regulating IKK activity, we
depletedMLK3 proteinwith RNAi in HEK293, SKOV3 and NIH3T3 cells
and analyzed the effect on IKK signaling.We found thatmlk3 silencing
elevated basal IKK activity, reduced basal IκBα protein levels, and
enhanced NF-κB-dependent gene expression. In addition, cells lacking
MLK3 were partially protected from etoposide-induced apoptotic cell
death. Consistent with these ﬁndings, overexpression of MLK3
promoted apoptotic cell death. Furthermore, overexpression of
MLK3 enhanced apoptotic cell death induced by etoposide treatment.
Taken together, our results suggest that MLK3 prevents NF-κB
activation by inhibiting IKK activity.
2. Materials and methods
2.1. Short hairpin RNA (shRNA) MLK3 expression plasmid
Murine MLK3 shRNAi oligo sequences were: Forward 5′-gat ccc c
GGG CAG CGA CGT GTC GAG CTT t tca aga gaa ctc cag acg tca ctg ccc ttt
ttg gaa a-3′ and Reverse 5′-agc ttt t CCC GTC GCT GCA CAG CTC GAA cc
aaa aag ggc agt gac gtc tgg agt tct ctt gaa act cca gac gtc act gcc cgg g-3′.
Annnealed DNA oligos were digested with HindIII and BglII and
ligated into pSUPER.retro.puro RNAi expression plasmid (Oligoengine,
WA, USA) that contains a puromycin resistance gene. Sequencing of
the ligation product was completed at the Ohio State University Plant
Microbe Genomics Facility.
2.2. Plasmid DNA and siRNA oligo transfections
To generate MLK3 shRNA stable cell lines, NIH-3T3 ﬁbroblasts
were transfected with 5 μg of the pSUPER-Retro-shMLK3 plasmid
using Lipofectamine 2000 from Invitrogen (Carlsbad, CA) according to
the manufacturer's instructions. Cells were incubated in selection
media containing 1 μg/ml puromycin and individual clones were
screened for MLK3 expression. Transfection of MLK3 siRNA oligos
were performed using Lipofectamine 2000 as previously described
[10]. Transient transfection of all plasmid DNA was performed using
Lipofectamine as previously described [23].
2.3. Real-time PCR (RT-PCR)
Total RNA from NIH3T3 shRNA clones was prepared using the
Absolutely RNA Minipreparation kit from Stratagene (La Jolla, CA)
according to the manufacturer's suggestions. RT-PCR was performed
using IQ SYBR Green Supermix from Bio-Rad (Hercules, CA) as
described previously [24]. The primer sequences were as follows:
mouse β-Actin Forward 5′-AGGTGTGCACCTTTTATTGGTCTCAA-3′,
Reverse 5′-TGTATGAAGTTTGGTCTCCCT-3′; mouse cIAP2 Forward 5′-
GAGGTGCTGGGAATCTGGAG-3′, Reverse 5′-CACCAGGCTCCTACT-
GAAGC-3′; mouse KC Forward 5′-ACCCGCTCGCTTCTCTGT-3′, Reverse
5′- CCAAGGGAGCTTCAGGGTCAAG-3′; and mouse IκBα Forward 5′-
CTGCAGGCCACCAACTACAA-3′, Reverse 5′-CAGCACCCAAAGTCAC-
CAAGT-3′.
2.4. Tissue culture
NIH3T3 mouse embryonic ﬁbroblasts, SKOV3 human ovarian
carcinoma cells and HEK293 human embryonic kidney cells were
obtained from American Type Culture Collection (Manassas, VA). All
cells were grown in a humidiﬁed atmosphere with 5% CO2 at 37 °C.
Cells were maintained in Dulbecco's modiﬁed Eagle's medium
supplemented with 10% bovine calf serum (NIH3T3) or 10% fetal
bovine serum (SKOV3 and HEK293), 25mg/mL streptomycin and 25 I.
U. penicillin from Cellgro (Mediatech Inc. Herndon, VA).2.5. Electrophoresis and immunoblotting
Cells were washed twice in phosphate buffered saline (PBS) and
lysed in 500 μL 2× SDS sample buffer. Cell lysates were collected and
subjected to 15% sodium dodecyl sulfate (SDS) polyacrylamide gel
electrophoresis (PAGE). The proteins were transferred to polyvinyli-
dene diﬂuoride (PVDF) membrane and probed with the appropriate
primary and secondary antibodies. Antibodies against the following
proteins were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA): MLK3, pp40/IκBβ, IKKγ, IκBα, and β-actin. Antibodies from Cell
Signaling Technology (Beverly, MA) used in this study were:
phospho-MLK3 (Thr277/Ser281), phospho-IκBα (Ser32/Ser36),
cleaved PARP and cleaved Caspase 3. Anti-FLAG antibody was
obtained from Stratagene. The secondary antibodies were Immun-
Star Goat Anti-Mouse-horse radish peroxidase (HRP) conjugate and
Immun-Star Goat Anti-Rabbit-HRP conjugate (Bio-Rad). Immobilon
western chemiluminescent HRP substrate from Millipore (Bedford,
MA) was used for chemiluminescent detection.2.6. TNFα and K252a treatment of cells
Cells were treated with vehicle or 20 ng/mL TNFα from Biosource
International (Camarillo, CA) for 10 min. For experiments where
phosphorylated IκBα was analyzed, TNFα treatments were for 0, 5,
20, and 40 min. For treatment of HEK293 cells with K252a, cells were
ﬁrst transfected with plasmid DNA. 24 h after DNA transfection, cells
were treated with 150 nM K252a for 5 h prior to treatment with
DMSO or etoposide.2.7. Analysis of cell death
4×105 of the HEK293 or shMLK3 cells were seeded on 6 cm tissue
culture dishes and incubated overnight at 37 °C. The next day, cells
were treated with etoposide (100 μM) from Sigma (St. Louis, MO) or
DMSO for 26 h. After treatment, the cells were stained with trypan
blue solution (0.4% w/v trypan blue in 1× PBS). Trypan blue-stained
cells (non-viable) and unstained cells (viable) were counted with a
hemocytometer and the percent of non-viable cells was calculated.
Photomicrographs of cells were taken with an Olympus (model IX51)
microscope using light microscopy under 400× magniﬁcation.
Analysis of apoptotic cell death was performed using the APOPercen-
tage apoptosis assay from Accurate Chemical (Westbury, NY)
according to the manufacturer's instructions. Caspase 3 and Caspase
7 activities were measured using the Caspase-Glo 3/7 apoptosis assay
system from Promega (Madison, WI) according to the manufacturer's
instructions. Statistical analyses were performed using Microsoft
Excel software. Data are presented as mean, with n representing 3
independent experiments. Comparison of two groups was performed
using unpaired Student's t test. A P value of b0.05 was regarded as
statistically signiﬁcant.2.8. IKK assay
GST-IκB protein preparation and IKK assay protocols were as
previously described [25,26]. Brieﬂy, 4×105 control or shMLK3 clones
4 and 2 cells were treated for 0, 20 and 40 min with 20 ng/ml
TNFα. IKKγ was immunoprecipitated from cell lysates and incu-
bated with 1 μg puriﬁed GST-IκBα, 10 mM MgCl2 and 0.1 mM ATP
at 30 °C for 30 min. Kinase assays were stopped by the addition of
2× SDS sample buffer and samples were boiled for 5 min before
being loaded onto the gel. Proteins were separated by SDS-PAGE,
transferred to PVDF membrane, and probed with anti-phospho-IκBα
antibody.
Fig. 1. Silencing mlk3 leads to a reduction in the level of IκB protein. (A) Whole cell
extracts from SKOV3 ovarian cancer cells transfected with nonspeciﬁc siRNA or human
MLK3 siRNA were subjected to SDS-PAGE and Western blotting with MLK3, IκBα, and
Actin (loading control) antibodies. (B) Whole cell extracts from control (transfected
with vector alone) and shMLK3 clones 1, 2, 4 and 7 were subjected to SDS-PAGE and
immunoblotted with MLK3, IκBα, and Actin antibodies. (C) Whole cell extracts from
control and shMLK3 clones 1, 2, 4 and 7 were subjected to SDS-PAGE and Western
blotting with MLK3, IκBα, IκBβ and Actin antibodies.
Fig. 2. Cells lacking MLK3 have elevated basal IKK activity. (A) HEK293 cells were
transfected with nonspeciﬁc or MLK3 siRNA oligos. IKKγwas immunoprecipitated from
cell lysates with IKKγ antibody and IKK assays were performed using GST-IκBα as
substrate. (B) Control and shMLK3 clones 4 and 2 cells were treated with 20 ng/mL
TNFα for 0 and 30 min. After TNFα treatments, IKKγwas immunoprecipitated from cell
lysates with IKKγ antibody and IKK assays were performed. Samples were subjected to
SDS PAGE and immunoblotted with IKKγ and phospho-IκBα antibodies. Phosphory-
lated GST-IκBα is indicated as p-GST-IκBα in the ﬁgure. (C) Control and clone 4 cells
were treated with 20 ng/mL TNFα for 0, 5 and 20 and 40 min. Whole cell extracts were
prepared and subjected to SDS PAGE and Western blotting with phospho-IκBα, IκBα
and Actin antibodies.
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3.1. Silencing mlk3 leads to a reduction in the level of IκBα protein
To investigate the role of MLK3 in NF-κB activation, we silenced
mlk3 expression in SKOV3 cells and analyzed the protein level of the
NF-κB inhibitor, IκBα. Phosphorylation of IκBα by IKK occurs in
response to TNF treatment and leads to ubiquitination and proteo-
somal degradation of IκBα [19]. Degradation of IκBα results in release
of associated NF-κB and exposure of the NF-κB nuclear localization
sequence which allows relocalization of NF-κB to the nucleus and
activation of gene transcription [19]. Surprisingly, we observed a
reduced level of IκBα protein 24 h and 48 h after transfection of
SKOV3 cells with MLK3 siRNA in comparison to cells transfected with
nonspeciﬁc siRNA oligos (Fig. 1A). To determine if a similar reduction
in IκBα levels occurred in cells stably expressing MLK3 shRNA,
NIH3T3 cells were prepared that stably expressed a MLK3 shRNA
plasmid (shMLK3). Individual clones expressing the MLK3 shRNA
were isolated in puromycin selection. Whole cell extracts were
prepared from the shMLK3 clones and MLK3 protein levels were
analyzed. shMLK3 clones 1, 2, 4, and 7 had reduced MLK3 protein
levels in comparison to control cells expressing vector alone (Fig. 1B).
Interestingly, the level of total endogenous IκBα protein was much
lower in shMLK3 cells in comparison to control cells (Fig. 1B).However, in these cells, MLK3 knockdown had little effect on the level
of endogenous IκBβ protein (Fig. 1C). The reduction of IκBα protein
levels was not due to decreased synthesis of IκBαmRNA since RT-PCR
of IκBα mRNA revealed an increase in the level of IκBα mRNA in
shMLK3 cells (Fig. 3A). These results demonstrate that cells lacking
MLK3 have reduced levels of IκBα protein. A reduction in the level of
IκBα protein in cells could elevate the amount of free NF-κB that can
translocate to the nucleus and activate gene transcription. Possibly,
the reduction in IκBα protein levels in shMLK3 cells is a result of
increased phosphorylation and degradation of IκBα.
3.2. Cells lacking MLK3 have elevated basal IKK activity
Next, wewished to determine if the decrease in IκBα protein levels
was due to a change in IκBα protein stability or turnover. If MLK3
inhibits IKK activity, then loss of MLK3 would relieve this inhibition
and augment endogenous IKK activity. To address this possibility, we
analyzed IKK activity in HEK293 cells transfected with MLK3 siRNA or
nonspeciﬁc siRNA oligos. IKKwas immunoprecipitatedwith anti-IKKγ
Fig. 3. Silencing mlk3 leads to elevated expression of NF-κB regulated genes. (A-C)
Control and shMLK3 (clones 4 and 2) cells were treated in triplicate with TNF for 0 and
60 min and then total RNA was isolated and real time PCR (RT-PCR) was performed
with primers speciﬁc for mouse IκBα, cIAP, KC and Actin. RT-PCR products were
analyzed and fold increase in gene expression was calculated.
Fig. 4. Silencing mlk3 renders cells resistant to etoposide-induced cell death. (A)
HEK293 cells were transfected with MLK3 siRNA or nonspeciﬁc siRNA oligos. Cells were
then treated with 200 μM etoposide or DMSO for 26 h. Dead cells were counted by
trypan blue exclusion and the fold-increase in dead cells was calculated. (B)
Photomicrographs of cells treated as described in A. (C) Extracts from cells in A, were
subjected to SDS PAGE and Western blotting with MLK3, cleaved PARP and Actin
antibodies. (D) Cells treated as described in A were analyzed with the APOPercentage
apoptosis assay system and percent-increase in apoptotic cells was determined. Each
bar represents the mean of data collected from 3 independent experiments and error
bars represent the standard error of the mean. An asterisk (⁎) indicates a statistically
signiﬁcant difference between samples indicated in the ﬁgure (Pb0.05).
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We observed an elevated basal level of endogenous IKK activity in
cells transfected with MLK3 siRNA in comparison to cells transfected
with nonspeciﬁc siRNA oligos (Fig. 2A). We then compared the TNF
stimulation of IKK activity in control and shMLK3 cells. We observed
that untreated shMLK3 cells had an elevated basal level of IKK activity
(Fig. 2B). This was similar to the result we observed when MLK3 was
silenced with siRNA oligos in HEK293 cells (Fig. 2A). TNF stimulation
induced a further increase in IKK activity in shMLK3 clone 4 cells and
in control cells (Fig. 2B). Interestingly, in comparison to shMLK3 cells,
control cells had elevated levels of phosphorylated IκBα (p-IκBα)
when treatedwith TNF for 0, 5 and 20min (Fig. 2C). Total IκBα protein
levels remained constant in control cells that were untreated or
treated with TNF for 5 min. After TNF stimulation for 20 or 40 min,
total IκBα protein levels declined (Fig. 2C). In the untreated, shMLK3
cells, total IκBα protein levels were lower than that of the untreated,
control cells, and the IκBα levels decreased upon TNF treatment for
20min and 40min. At 40min, there was no detectable IκBα protein in
the shMLK3 clone 4 cells (Fig. 2C). These data indicate that silencing
mlk3 elevates basal IKK activity and enhances phosphorylation and
degradation of IκBα.
3.3. Silencing mlk3 leads to elevated expression of NF-κB regulated genes
Since shMLK3 cells had elevated basal IKK activity, we predicted
that these cells would also have elevated basal NF-κB-dependent gene
expression. To test this possibility, we measured the transcription ofspeciﬁc NF-κB regulated genes in shMLK3 cells. Indeed, the basal
levels of NF-κB regulated genes IκBα, cellular inhibitor of apoptosis 2
(cIAP2) and KC were higher in the shMLK3 cells in comparison to the
control cells (Fig. 3A–C). Gene expression was further increased upon
treatment of shMLK3 cells with TNF (Fig. 3A–C). These results are
consistent with the MLK3 shRNA clones having elevated IKK activity.
Furthermore, these results suggest that MLK3 may function to limit
IKK activity and, therefore, loss of MLK3 could lead to elevated IKK
activity and NF-κB dependent gene expression.
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We postulated that elevated NF-κB dependent, pro-survival gene
expression in cells lackingMLK3would confer resistance of these cells
to etoposide-induced apoptotic cell death. To test this, mlk3 was
silenced with siRNA oligos in HEK293 cells. Cells were then treated
with DMSO or etoposide for 26 h and cell death was analyzed. In cells
transfected with nonspeciﬁc siRNA oligos, etoposide induced a 17.3-
fold increase in the number of dead cells (Fig. 4A). In cells transfected
with the MLK3 siRNA oligos, etoposide induced only 7.3-fold increase
in the number of dead cells indicating that HEK293 cells lacking MLK3
are partially resistant to etoposide-induced cell death (Fig. 4A).Fig. 5. shMLK3 cells are resistant to etoposide-induced apoptotic cell death and caspase ac
DMSO for 26 h. Dead cells were counted by trypan blue exclusion and the fold-increase in dea
A, and the fold-increase in dead cells was calculated. (C) Control and shMLK3 clone 4 and c
blotting with IκBα, MLK3 and Actin antibodies. (D) Photomicrographs of cells treated with D
with etoposide for various time intervals (as indicated) and cell extracts were prepared and s
(F) Cells treated with DMSO or etoposide as described in A, were analyzed with the Caspase-
Each bar represents the mean of data collected from 3 independent experiments and error
signiﬁcant difference between samples indicated in the ﬁgure (Pb0.05).Protection of MLK3 knockdown cells from etoposide-induced cyto-
toxicity was also evident in photomicrographs of DMSO- and etopo-
side-treated cells (Fig. 4B). Etoposide treatment caused cells to round
up and dead cells lifted off the dish. The photomicrograph shows
the remaining adherent cells after 26 h treatment with etoposide
(Fig. 4B). To determine if cell death induced by etoposide treatment
was apoptotic cell death, we analyzed cell lysates for the presence of
cleaved PARP. Cleaved PARP was observed only in cells treated with
etoposide. Furthermore, the level of cleaved PARP was much lower in
cells transfected with MLK3 siRNA in comparison to cells transfected
with nonspeciﬁc siRNA, indicating that the induction of apoptotic cell
death by etoposide was impaired in cells lacking MLK3 (Fig. 4C).tivation. (A) Control and shMLK3 clone 4 cells were treated with 200 μM etoposide or
d cells was calculated. (B) Control and shMLK3 clone 2 cells were treated as described in
lone 2 cell extracts prepared from cells in A, were subjected to SDS PAGE and Western
MSO and etoposide as described in A. (E) Control and shMLK3 clone 4 cells were treated
ubjected to SDS PAGE andWestern blotting with cleaved Caspase 3 and Actin antibodies.
Glo 3/7 apoptosis assay system and the fold-increase in apoptotic cells was determined.
bars represent the standard error of the mean. An asterisk (⁎) indicates a statistically
Fig. 6. Expression of MLK3 sensitizes cells to etoposide-induced cell death. (A) HEK293
cells were transfected with MLK3-WT or MLK3-KD expression plasmids or control
pCMV5 vector. Cells were treated with 100 μMetoposide or DMSO for 24 h. Cells treated
with the K252a inhibitor were incubated with the inhibitor for 5 h prior to treatment of
cells with DMSO or etoposide. Dead cells were counted by trypan blue exclusion and the
fold-increase in dead cells was calculated. (B) Photomicrographs of cells treated as
described in A. (C) Cell lysates were prepared as in A, but collected 6 h prior to counting
and then subjected to SDS PAGE andWestern blotting with FLAG, cleaved PARP, pMLK3
and Actin antibodies. (D) Cells treated as described in A were analyzed with the
APOPercentage apoptosis assay system and the percent-increase in apoptotic cells was
determined. Each bar represents the mean of data collected from 3 independent
experiments and error bars represent the standard error of the mean. An asterisk (⁎)
indicates a statistically signiﬁcant difference between samples indicated in the ﬁgure
(Pb0.05).
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apoptosis assay system. Cells transfected with nonspeciﬁc siRNA
oligos had a 30% increase in etoposide-induced apoptosis in
comparison to cells transfected with MLK3 siRNA, which had a 7%
increase in etoposide-induced apoptosis (Fig. 4D).
We also analyzed etoposide-induced cell death in control cells and
shMLK3 cells that exhibited reduced MLK3 and IκBα protein levels
(Fig. 5C). In the control cells, etoposide induced a 12.7-fold increase in
the number of dead cells, while the shMLK3 clone 4 cells displayed a
7.9-fold increase in the number of dead cells upon etoposide
treatment (Fig. 5A). Similarly, in shMLK3 clone 2 cells, etoposide
induced only a 3.4-fold increase in cell death in comparison to 9.0-fold
increase observed in the control cells (Fig. 5B). The protection of
shMLK3 cells from etoposide-induced cell death is also evident in the
photomicrographs in Fig. 5D that show the remaining adherent cells
after 26 h DMSO or etoposide treatment. Cleaved Caspase 3 was also
observed in control cells treated with etoposide at 13, 15 and 17 h,
however, no cleaved Caspase 3 was observed in the shMLK3 cells
treated with etoposide for 17 h (Fig. 5E). The Caspase Glo 3/7
apoptosis assay system was used to analyze Caspase 3 and 7 activities
associated with apoptotic cell death. A 3.4-fold increase in Caspase 3/
7 activity was induced by etoposide treatment in control cells in
comparison to a 1.2- to 1.4-fold increase induced by etoposide in
shMLK3 cells (Fig. 5F). Taken together, these results suggest that
silencingmlk3 expression inhibits etoposide-induced Caspase 3 and 7
activities and renders cells partially resistant to etoposide-induced
apoptotic cell death.
3.5. Expression of MLK3 sensitizes cells to etoposide-induced cell death
Cells lacking MLK3 are resistant to etoposide-induced cell death,
suggesting that MLK3 may have an important role in inducing cell
death in response to etoposide treatment. Thus, we tested if
overexpressing wild type FLAG-MLK3 (MLK3-WT) in HEK293 cells
could enhance etoposide-induced cell death. Interestingly, expres-
sion of MLK3-WT alone in HEK293 cells induced 1.8-fold more cell
death than control cells expressing vector alone (Fig 6A, B).
Expression of a kinase-dead mutant (K144A) of MLK3 (MLK3-KD)
resulted in 1.7-fold more cell death in comparison to vector alone
(Fig. 6A, B). In addition, overexpression of either FLAG-MLK3-WT or
FLAG-MLK3-KD enhanced etoposide-induced cell death (Fig. 6A, B).
The kinase activity of MLK3 is important for enhancing etoposide-
induced cell death since MLK3-WT was much more effective in
enhancing etoposide-induced cell death than MLK3-KD (Fig. 6A, B).
Furthermore, enhancement of etoposide-induced cell death by
MLK3-WT was reduced by treatment of cells with K252a, a
neuroprotective compound that is a potent inhibitor of MLK3 kinase
activity (Fig. 6A, B) [27]. Cleaved PARP was observed in cells treated
with etoposide or transfected with MLK3-WT or MLK3-KD, but not in
cells transfected with empty vector suggesting that overexpressing
MLK3 alone triggers apoptotic cell death (Fig. 6C). For cells treated
with etoposide, MLK3-WT was more effective at inducing PARP
cleavage than MLK3-KD (Fig. 6C). Consistent with these ﬁndings,
enhancement of etoposide-induced cleavage of PARP by MLK3-WT
was substantially reduced in cells treated with K252a (Fig. 6C). Our
results suggest an anti-survival function for MLK3, which is in
agreement with the observation that MLK3-WT, MLK3 WT + K252a
treatment or MLK3-KD overexpression had no signiﬁcant effect on
IκBα protein levels. These results also indicate that inhibition of IKK
signaling by MLK3 does not require MLK3 kinase activity. (Fig. 6C).
Using the APOPercentage apoptosis assay system, we observed
that etoposide induced a 19% increase in apoptosis in HEK293 cells
expressing vector alone. In cells expressing MLK3-WT, etoposide
induced a 24% increase in apoptosis in comparison to DMSO treatment
(Fig. 6D). For cells expressing MLK3-KD, etoposide induced a 24%
increase in apoptosis, however, cells expressing MLK3-WT andtreated with K252a had no signiﬁcant increase in apoptotic cell
death in comparison to DMSO treatment (Fig. 6D). The reduction in
etoposide-induced PARP cleavage and apoptosis was more
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comparison to cells expressing MLK3-KD. This difference could be due
to the fact that K252a treatment of cells can also cause activation of
the AKT pro-survival signaling pathway [27]. Collectively, these
results suggest that MLK3 overexpression induces cleavage of PARP
and apoptosis. Furthermore, MLK3 overexpression can sensitize cells
to etoposide-induced apoptotic cell death.
4. Discussion
To gain a better understanding of the function of endogenous
MLK3 in regulation of IKK activation, we silenced mlk3 expression by
RNAi and analyzed the effect on IKK activity and NF-κB-dependent
gene expression. We observed that both NIH3T3 cells stably
expressing MLK3 shRNA and SKOV3 cells transiently transfected
with MLK3 siRNA oligos had reduced levels of IκBα protein.
Previously it was reported that IκBα protein levels were unaffected
in mouse embryonic ﬁbroblasts (MEFs) from MLK3 knockout mice in
comparison to wild type MEFs [12]. Possibly, in the MLK3 knockout
MEFs, one of the other members of the MLK family (MLK 1, 2 and 4)
may have compensated for MLK3 function during development.
To determine the effect of reduced MLK3 protein levels on IKK
activity, we compared the IKK activity in control cells and cells in
which mlk3 expression was silenced with RNAi. We observed that
cells lackingMLK3 protein had an elevated level of basal IKK activity in
comparison to control cells. These results suggest that MLK3 has an
inhibitory effect on IKK activity that is released whenmlk3 expression
is silenced. MLK3-dependent inhibition of IKK activity could occur
indirectly through inhibition of an upstream IKKK such as NIK or
TAK1. However, since MLK3 has been previously shown to directly
associate with IKKα and IKKβ catalytic subunits, it is possible that
MLK3 inhibits IKK activity directly through its interactionwith the IKK
catalytic subunits [6]. Hehner et al. [6] previously showed that
overexpression of MLK3 stimulated IKK activity in Jurkat T cells. Our
results using MLK3 RNAi in NIH3T3 and HEK293 cells suggest that
MLK3 has an inhibitory effect on IKK activity. Possibly, the differences
between the cell lines studied and the approaches employed could
account for the variation in results obtained between these two
studies [6,21].
In addition to having elevated basal IKK activity, cells depleted of
MLK3 also had an elevated basal level of NF-κB-dependent gene
expression (cIAP, IκBα, and KC). Consistent with these ﬁndings,
elevated TNF-induced expression of IL-6, another NF-κB regulated
gene, was previously observed in MLK3 deﬁcient MEFs [12].
Upregulation of NF-κB pro-survival signaling could protect cells
against cell death induced by various pro-apoptotic stimuli such as the
DNA topoisomerase inhibitor, etoposide. Etoposide induces double
strand breaks in DNA and triggers a p53-dependent activation of Bax
transcription and apoptosis [28]. We observed that MLK3-deﬁcient
cells were partially resistant to etoposide-induced cell death in
comparison to control cells. These data suggest that MLK3 has an anti-
survival function and are in agreement with the enhanced IKK activity
and NF-κB dependent gene expression observed in cells lackingMLK3.
MLK3 has been implicated in the activation of apoptotic cell death
in neuronal and hepatoma cells. In serum-deprived neuronal cells,
MLK3 induces apoptotic cell death through activation of JNK signaling
[13,14]. Inhibition of MLK3 kinase activity with CEP1347 increases the
survival of neurons that have been deprived of nerve growth factor
[13]. In hepatoma cells, MLK3 activation of p38was found to be critical
for TGFβ-induced apoptosis [9]. Given the pro-apoptotic function of
MLK3 in hepatoma and neuronal cells, we analyzed the effect of
overexpressing MLK3 on the induction of apoptosis in HEK293 cells.
We observed that MLK3 expression alone, triggered apoptotic cell
death in HEK293 cells. Stimulation of apoptosis by MLK3 could occur
through its direct activation of MAP2Ks that regulate JNK or p38
signaling. However, in HEK293 cells, overexpression of the kinase-dead form of MLK3 also activated apoptosis, suggesting that MLK3 can
activate apoptosis through a mechanism that is independent of its
kinase activity. Possibly, MLK3 can also function as a scaffold protein
facilitating activation of other apoptotic signaling pathways indepen-
dent of JNK or p38.
Interestingly, MLK3-WT expression was more effective in enhan-
cing etoposide-induced cell death than MLK3-KD. These results
suggest that MLK3 kinase activity is important for enhancement of
etoposide-induced cell death. Since prolonged, rather than transient
activation of JNK promotes apoptosis, it is possible that overexpres-
sion of MLK3 caused sustained JNK activation resulting in enhance-
ment of etoposide-induced apoptotic cell death.
Collectively, our observations suggest an anti-survival role for
endogenous MLK3 in NIH3T3, SKOV3 and HEK293 cells. TNF activates
both pro-apoptotic signaling and pro-survival NF-κB signaling and
ultimately, the decision between life and death is dependent on the
balance between these opposing pathways [29]. In unstimulated cells,
MLK3may limit IKK activity and prevent inappropriate IKK activation.
Upon cytokine stimulation, recruitment of MLK3 to JNK and p38
MAPK signaling pathways may relieve the inhibition on IKK activity.
Similarly, depletion of MLK3 protein with RNAi removes the block on
IKK activity and elevates basal IKK activity and NF-κB-dependent gene
expression.
Our previous observations indicated that silencing mlk3 in normal
and tumor cells inhibited MAPK signaling and cell proliferation [10].
Herein, we observed that cells lacking MLK3 also have increased IKK
activity and enhanced NF-κB-dependent gene expression. Thus,
targeting MLK3 would have the combined effect of inhibiting cell
proliferation and enhancing cell survival.
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